IL6 and diabetes mellitus: Experimental evidence found that patients with diabetes have chronic low-grade inflammation marked by higher levels of pro-inflammatory mediators including C-reactive protein, interleukin 6, and tumor necrosis factor alpha, as well as abnormal cytokine-secreting cells [17].